Loading...
The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia
Romiplostim is a thrombopoietin peptide mimetic agent recently approved for the treatment of adults with chronic immune thrombocytopenia (ITP). In randomized controlled studies, this agent has demonstrated an increase in the platelet count in the majority of patients with ITP, both in splenectomized...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627322/ https://ncbi.nlm.nih.gov/pubmed/23616916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620712453596 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|